NRAS and melanoma: As the mitogen-activated protein kinase (BRAF-MAPK) signaling pathway is frequently activated in melanoma [29], we analyzed TERT in melanoma subtypes with hotspot mutations in BRAF, RAS (NRAS, KRAS, HRAS) and NF1 genes in the SKCM cohort.